The company lost $4.9 million during the same time period in 2011 and $29.9 million by the year’s end. Its 2011 losses totaled only $18.2 million.
TranS1’s total operating expenses were up nearly 85 percent from the fourth quarter 2011, from $7.9 million to $14.5 million. Included in operating expenses was a $6.6 million charge related to a U.S. government settlement. TranS1 paid a total of $32.9 million toward the settlement in 2011 and $40 million in 2012.
In a move to expand its focus on minimally invasive lumber spine treatments, TranS1 recently acquired Baxano, a manufacturer of spinal decompression devices.
More Articles on Devices:
Symmetry Medical Launches Self-Retaining Rotilt Ratchet
AxoGen Names Shawn McCarrey as Senior VP of Sales
Lanx Releases ALTA Cervical Spine Fusion Device
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.